Bruce Dudzik has been named senior director of business development at NanoInk, the company said this week.
Dudzik joins NanoInk from Affymetrix where he served at senior levels of business development. Dudzik also held positions at Amersham, now GE Healthcare, Vysis, now Abbott Labs, and Amoco's biotechnology division.
Dudzik received an MBA from DePaul University and holds a BS in biology from the University of Illinois, Urbana-Champaign.
Bill Brammer has joined the board of directors of VizX Labs, the company said last week. He is director of small and mid-market solutions and partner business management at Microsoft.
Mark Crane has become vice president of marketing and business development for Gene Logic's preclinical division, the company said last week. Previously, he held positions in sales and marketing at Quest Pharmaceutical Services, MDS Pharma Services, Avantec, and PerkinElmer. At GeneLogic, he will be responsible for sales and marketing of preclinical services to pharmaceutical and biotechnology companies and to government organizations.
Nicholas Ventresca has become corporate senior vice president of information technology as well as chief information officer of Charles River Laboratories, the company said last week. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn.